Mostrando 7 resultados de: 7
Publisher
Drug Discovery Today(3)
Challenges and Advances in Computational Chemistry and Physics(1)
Current Pharmaceutical Design(1)
Journal of Cheminformatics(1)
SAR and QSAR in Environmental Research(1)
Área temáticas
Farmacología y terapéutica(4)
Bioquímica(2)
Química física(2)
Dirección general(1)
El libro(1)
Conformation-dependent QSAR approach for the pbkp_rediction of inhibitory activity of bromodomain modulators
ArticleAbstract: Epigenetic drug discovery is a promising research field with growing interest in the scientific commPalabras claves:3D molecular descriptors, Applicability domain, Bromodomains, epigenetic drug discovery, QSAR, QuBiLS-MIDAS, ToMoCoMD-CARDDAutores:César R. García-Jacas, Martinez-Mayorga K., Medina-Franco J.L., Yovani Marrero-PonceFuentes:scopusDatabase fingerprint (DFP): an approach to represent molecular databases
ArticleAbstract: Background: Molecular fingerprints are widely used in several areas of chemoinformatics including diPalabras claves:DIVERSITY, Information content, Molecular fingerprints, Shannon entropy, similarityAutores:César R. García-Jacas, Fernández-De Gortari E., Martinez-Mayorga K., Medina-Franco J.L.Fuentes:scopusActivity cliffs in drug discovery: Dr Jekyll or Mr Hyde?
ReviewAbstract: The impact activity cliffs have on drug discovery is double-edged. For instance, whereas medicinal cPalabras claves:Autores:Borges F., Maykel Cruz-Monteagudo, Medina-Franco J.L., Natalia Dias Soeiro Cordeiro M., Nicolotti O., Yunierkis Perez-CastilloFuentes:scopusFrom flamingo dance to (desirable) drug discovery: a nature-inspired approach
ReviewAbstract: The therapeutic effects of drugs are well known to result from their interaction with multiple intraPalabras claves:Autores:Aminael Sánchez-Rodríguez, Borges F., Eduardo Tejera, Mangiatordi G.F., Maykel Cruz-Monteagudo, Medina-Franco J.L., Natalia Dias Soeiro Cordeiro M., Nicolotti O., Schürer S.C., Yunierkis Perez-CastilloFuentes:googlescopusQuantitative structure-epigenetic activity relationships
Book PartAbstract: The relevance of epigenetic drug discovery has increased during the past few years as revealed by thPalabras claves:Activity cliffs, Activity landscape, Bromodomains, DNA methyltransferase, Epi-informatics, Epigenetics, HDAC, SEARSAutores:García-Sánchez M.O., Maykel Cruz-Monteagudo, Medina-Franco J.L.Fuentes:scopusProbing the hypothesis of SAR continuity restoration by the removal of activity cliffs generators in QSAR
ReviewAbstract: In this work we report the first attempt to study the effect of activity cliffs over the generalizatPalabras claves:Activity cliffs, Activity cliffs generators, chemoinformatics, Machine learning, QSAR, Virtual ScreeningAutores:Aminael Sánchez-Rodríguez, Borges F., Cesar Paz-y-Miño, Contreras-Posada Z., Eduardo Tejera, Maykel Cruz-Monteagudo, Medina-Franco J.L., Natalia Dias Soeiro Cordeiro M., Perera-Sardiña Y., Yunierkis Perez-CastilloFuentes:googlescopusSystemic QSAR and phenotypic virtual screening: chasing butterflies in drug discovery
ReviewAbstract: Current advances in systems biology suggest a new change of paradigm reinforcing the holistic naturePalabras claves:Autores:Aminael Sánchez-Rodríguez, Borges F., Eduardo Tejera, Maykel Cruz-Monteagudo, Medina-Franco J.L., Schürer S.C., Yunierkis Perez-CastilloFuentes:googlescopus